Auto-Assembling Detoxified Staphylococcus aureus Alpha-Hemolysin Mimicking the Wild-Type Cytolytic Toxin

Clin Vaccine Immunol. 2016 Jun 6;23(6):442-50. doi: 10.1128/CVI.00091-16. Print 2016 Jun.

Abstract

Staphylococcus aureus alpha-hemolysin (Hla) assembles into heptameric pores on the host cell membrane, causing lysis, apoptosis, and junction disruption. Herein, we present the design of a newly engineered S. aureus alpha-toxin, HlaPSGS, which lacks the predicted membrane-spanning stem domain. This protein is able to form heptamers in aqueous solution in the absence of lipophilic substrata, and its structure, obtained by transmission electron microscopy and single-particle reconstruction analysis, resembles the cap of the wild-type cytolytic Hla pore. HlaPSGS was found to be impaired in binding to host cells and to its receptor ADAM10 and to lack hemolytic and cytotoxic activity. Immunological studies using human sera as well as sera from mice convalescent from S. aureus infection suggested that the heptameric conformation of HlaPSGS mimics epitopes exposed by the cytolytic Hla pore during infection. Finally, immunization with this newly engineered Hla generated high protective immunity against staphylococcal infection in mice. Overall, this study provides unprecedented data on the natural immune response against Hla and suggests that the heptameric HlaPSGS is a highly valuable vaccine candidate against S. aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM10 Protein / metabolism
  • Animals
  • Bacterial Toxins / administration & dosage
  • Bacterial Toxins / chemistry*
  • Bacterial Toxins / genetics
  • Bacterial Toxins / immunology*
  • Cell Line
  • Cytotoxins
  • Epitopes / immunology
  • Escherichia coli / genetics
  • Hemolysin Proteins / administration & dosage
  • Hemolysin Proteins / chemistry*
  • Hemolysin Proteins / genetics
  • Hemolysin Proteins / immunology*
  • Humans
  • Membrane Proteins / metabolism
  • Mice
  • Microscopy, Electron, Transmission
  • Models, Molecular
  • Molecular Mimicry*
  • Protein Engineering
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Recombinant Proteins / isolation & purification
  • Staphylococcal Infections / prevention & control*
  • Staphylococcal Vaccines / immunology
  • Staphylococcus aureus* / chemistry
  • Staphylococcus aureus* / metabolism
  • Vaccination

Substances

  • Bacterial Toxins
  • Cytotoxins
  • Epitopes
  • Hemolysin Proteins
  • Membrane Proteins
  • Recombinant Proteins
  • Staphylococcal Vaccines
  • staphylococcal alpha-toxin
  • ADAM10 Protein

Grants and funding

At the time the study was conducted, Novartis Vaccines and Diagnostics, Inc., was the funding source.